A Common Molecular Signature in Heart, Liver and Kidney Defines Fibrosis in Chronic Deseases
A Common Molecular Signature in Heart, Liver and Kidney Defines Fibrosis in Chronic Deseases
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
The scientific aim of PerMediK is to support the development of a path towards personalized medicine in chronic kidney disease (CKD), based on multidimensional -omics data (Big Data).
MoU – 079/22
CSO Approval date – 27/05/2022
Start date – 13/10/2022
End date – 12/10/2026
This website is based upon work from COST Action PerMediK, CA21165, supported by COST (European Cooperation in Science and Technology).
Design by Boutik
